Early and Late Pathomechanisms in Alzheimer's Disease: From Zinc to Amyloid-β Neurotoxicity
Overview
Authors
Affiliations
There are several systemic and intracerebral pathologic conditions, which limit provision and utilization of energy precursor metabolites in neuronal cells. Energy deficits cause excessive depolarization of neuronal cells triggering glutamate-zinc evoked excitotoxic cascade. The intracellular zinc excess hits several intraneuronal targets yielding collapse of energy balance and impairment functional and structural impairments cholinergic neurons. Disturbances in metabolism of acetyl-CoA, which is a direct precursor for energy, acetylcholine, N-acetyl-L-aspartate and acetylated proteins synthesis, play an important role in these pathomechanisms. Disruption of brain homeostasis activates slow accumulation of amyloid-β , which extra and intracellular oligomeric deposits disrupt diverse transporting and signaling processes in all membrane structures of the cell. Both neurotoxic signals may combine aggravating detrimental effects on neuronal cell. Different neuroglial and neuronal cell types may display differential susceptibility to similar pathogenic insults depending on specific features of their energy and functional parameters. This review, basing on findings gained from cellular and animal models of Alzheimer's disease, discusses putative energy/acetyl-CoA dependent mechanism in early and late stages of neurodegeneration.
Metabolic and Cellular Compartments of Acetyl-CoA in the Healthy and Diseased Brain.
Jankowska-Kulawy A, Klimaszewska-Lata J, Gul-Hinc S, Ronowska A, Szutowicz A Int J Mol Sci. 2022; 23(17).
PMID: 36077475 PMC: 9456256. DOI: 10.3390/ijms231710073.
Role of Cholinergic Signaling in Alzheimer's Disease.
Chen Z, Huang J, Yang S, Hong F Molecules. 2022; 27(6).
PMID: 35335180 PMC: 8949236. DOI: 10.3390/molecules27061816.
Shurubor Y, Cooper A, Krasnikov A, Isakova E, Deryabina Y, Beal M Int J Mol Sci. 2020; 21(23).
PMID: 33255464 PMC: 7727790. DOI: 10.3390/ijms21238918.
Gu X, Zhao H, Zhou J, Zhou Y, Wei X, Wang H Evid Based Complement Alternat Med. 2020; 2020:6212907.
PMID: 31976005 PMC: 6959142. DOI: 10.1155/2020/6212907.
Deme P, Rojas C, Slusher B, Rais R, Afghah Z, Geiger J Exp Neurol. 2020; 327:113181.
PMID: 31930991 PMC: 7233457. DOI: 10.1016/j.expneurol.2020.113181.